StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Gilead Sciences (GILD) PT Lowered to $87 at RBC Capital
October 26, 2018 7:24 AM
RBC Capital analyst Brian Abrahams ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Next Articles
Gilead Sciences (GILD) Reports 96-Wk Data from Phase 3 Study of Biktarvy (Bictegravir, Emtricitabine, Tenofovir Alafenamide) for HIV-1 Treatment in Adults New to HIV Therapy
October 30, 2018 7:17 AM
Piper Jaffray Downgrades Gilead Sciences (GILD) to Neutral
October 26, 2018 4:41 AM
Gilead Sciences (GILD) PT Raised to $95 at Barclays
October 26, 2018 3:57 AM
Gilead Sciences (GILD) Declares $0.57 Quarterly Dividend; 3.3% Yield
October 25, 2018 5:20 PM
Form 8-K GILEAD SCIENCES INC For: Oct 25
October 25, 2018 4:12 PM
Gilead Sciences (GILD) Tops Q3 EPS by 21c, Offers Guidance
October 25, 2018 4:06 PM
Gilead Sciences Announces Fourth Quarter 2018 Dividend
October 25, 2018 4:02 PM
